Vaginal Bromocriptine for Treatment of Adenomyosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

January 31, 2018

Conditions

Adenomyosis

Interventions

DRUG

Vaginal Bromocriptine

Patients will receive 2.5 mg of vaginal bromocriptine tablet twice a day for the intervention. This will be administered for 6 months.

Trial Locations (1)

Mayo Clinic in Rochester, Rochester